Small Pulmonary Nodules: Reproducibility of Three-dimensional Volumetric Measurement and Estimation of Time to Follow-up CT

PURPOSE: To determine reproducibility of volume measurements of small pulmonary nodules on computed tomographic (CT) scans and to estimate critical time to follow-up CT.

MATERIALS AND METHODS: One hundred fifteen pulmonary nodules for which two thin-section small–field-of-view CT scans were obtained and which were stable during 2-year observation were evaluated. A standard group of 94 nodules (with no or minimal artifact) and an expanded group of 105 nodules (including those with moderate artifacts) were examined. Percentage volume change (PVC) and monthly volumetric growth index (MVGI) were computed for each nodule pair. By using estimates of the variation in PVC in stable nodules as a function of initial diameter, critical time to follow-up CT was estimated; this time is the earliest point at which growth in a nodule of a given size can be reliably identified with repeat CT.

RESULTS: The SD of PVC decreased with increasing nodule size from 18.5% in 2–5-mm nodules to 10.6% in 5–8-mm nodules and to 7.47% in 8–10-mm nodules. Inclusion of cases with moderate motion artifacts increased the SD of PVC to 27.4% in 2–5-mm nodules, to 17.1% in 5–8-mm nodules, and to 19.3% in 8–10-mm nodules. Critical time to follow-up CT for nodules detected at baseline screening was 12, 5, and 3 months and 1 month for those with initial sizes of 2, 5, 8, and 10 mm, respectively. For nodules detected at annual repeat screening, it was 4 and 3 months and 1 month for nodules that were 3, 4, and 5 mm or larger in size, respectively. Mean MVGI in 94 standard cases was 0.06%, and standard error was 0.21%.

CONCLUSION: Factors that affect reproducibility of nodule volume measurements and critical time to follow-up CT include nodule size at detection, type of scan (baseline or annual repeat) on which the nodule is detected, and presence of patient-induced artifacts.

© RSNA, 2004


  • 1 Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105. Crossref, MedlineGoogle Scholar
  • 2 Henschke CI, Naidich DP, Yankelevitz DF, et al. Early Lung Cancer Action Project: initial findings on repeat screenings. Cancer 2001; 92:153-159. Crossref, MedlineGoogle Scholar
  • 3 Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956; 76:988-1000. MedlineGoogle Scholar
  • 4 Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962; 79:221-231. LinkGoogle Scholar
  • 5 Yankelevitz DF, Gupta R, Zhao B, Henschke CI. Small pulmonary nodules: evaluation with repeat CT—preliminary experience. Radiology 1999; 212:561-566. LinkGoogle Scholar
  • 6 Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217:251-256. LinkGoogle Scholar
  • 7 Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation of solitary pulmonary nodules from helical CT scans. In: Lemke HU, Vannier MW, Inamura K, Farman AG, eds. Proceedings of Computer Assisted Radiology and Surgery (CARS ‘99). Amsterdam, the Netherlands: Elsevier Science, 1999; 203-207. Google Scholar
  • 8 Reeves AP, Kostis WJ. Computer-aided diagnosis of small pulmonary nodules. Semin Ultrasound CT MR 2000; 21:116-128. Crossref, MedlineGoogle Scholar
  • 9 Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images. IEEE Trans Med Imaging 2003; 22:1259-1274. Crossref, MedlineGoogle Scholar
  • 10 Reeves AP, Yankelevitz DF, Kostis WJ, Henschke CI. Volumetric growth index (VGI) for small pulmonary nodules: development and validation (abstr). Radiology 2001; 221(P):311-312. Google Scholar
  • 11 Geddes DM. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest 1979; 73:1-17. Crossref, MedlineGoogle Scholar
  • 12 Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 1997; 65:284-297. Crossref, MedlineGoogle Scholar
  • 13 Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 1961; 14:1272-1294. Crossref, MedlineGoogle Scholar
  • 14 Weiss W. Tumor doubling time and survival of men with bronchogenic carcinoma. Chest 1974; 65:3-8. Crossref, MedlineGoogle Scholar
  • 15 Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS, ELCAP Group. Screening for lung cancer: the early lung cancer action approach. Lung Cancer 2002; 35:143-148. Crossref, MedlineGoogle Scholar
  • 16 Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178:1053-1057. Crossref, MedlineGoogle Scholar
  • 17 Reeves AP, Kostis WJ, Yankelevitz DF, Henschke CI. Three-dimensional analysis of ground glass opacities in helical CT scans (abstr). Radiology 2000; 217(P):384. Google Scholar

Article History

Published in print: May 2004